Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  epirubicin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-25 of 255 for your search:
Start Over
Traditional (Traditional Chemoembolization) TACE Versus Microsphere TACE
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RAD01, EudraCT 2006-003034-15, NCT00936689
Phase II/III Randomized Study of Two Dose Levels of Epirubicin vs ADR in Patients with Disseminated Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: BGSM-74484, NCI-V85-0227
Phase II/III Randomized Study of Two Dose Levels of Epirubicin vs ADR in Patients with Disseminated Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: NYH-068004-087, NCI-V86-0129
Phase II/III Randomized Study of Two Dose Levels of Epirubicin vs ADR in Patients with Disseminated Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: YALE-HIC-3709, NCI-V86-0094
Phase II/III Randomized Comparison of DOX vs Two Schedules of High-Dose Epirubicin in Patients with Advanced Soft Tissue Sarcoma
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor:
Protocol IDs: EORTC-62901
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: GEICAM/2006-14, Nº EudraCT 2007-007031-13, NCT00841828
Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000641309, PACT-7, SRSI-PACT-7, EU-20932, NCT00960284
Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 65 and over
Sponsor: Other
Protocol IDs: GBG 52, 2008-003995-23, NCT01204437
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: FLOT4, NCT01216644
Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: DLBS1425-0310, NCT01433562
Phase III Randomized Study of Epirubicin/Vinorelbine vs Epirubicin Alone for Advanced Breast Cancer (Summary Last Modified 06/1999)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor:
Protocol IDs: DAN-DBCG-94-03, EU-95008
Phase III Randomized Study of Unrelated Donor BMT vs Continuing Chemotherapy for Childhood Acute Lymphoblastic Leukemia in First Relapse
Phase: Phase III
Type: Treatment
Status: Closed
Age: under 15 at initial diagnosis
Sponsor:
Protocol IDs: MRC-LEUK-UKALL-R2, EU-95039
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer
Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: 16 to 65
Sponsor: Other
Protocol IDs: CDR0000064834, IBCSG-15-95, EU-96021, NCT00002784
Phase III Randomized Study of Tamoxifen or Cyclophosphamide/Epirubicin/Fluorouracil (CEF) Following Local Treatment for Recurrent Breast Cancer (Summary Last Modified 07/97)
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 74
Sponsor:
Protocol IDs: DAN-DBCG-9505, SBG-94-1, EU-95010
High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Phase: Phase III
Type: Treatment
Status: Completed
Age: under 60
Sponsor: Other
Protocol IDs: PEGASE03, FRE-FNCLCC-PEGASE03, EU-96032, NCT00002870
Phase III Study of Fluorouracil/Epirubicin/Cyclophosphamide vs Fluorouracil/Epirubicin/Cyclophosphamide/Filgrastim (G-CSF) in Patients with Early Breast Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: 70 and under
Sponsor:
Protocol IDs: CNR-012307, EU-95017
Start Over